Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-16 · accession 0000874015-24-000180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-07-17 | 2024-07-16 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $50.00 | -12.0K | 0 | -100% | -$600.0K |
| DI | 2024-07-17 | 2024-07-16 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $24.42 | +12.0K | 12.0K | New | +$293.0K |
| DI | 2024-07-17 | 2024-07-16 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-16 | S | D | 12,000 | $50.00 | 0 | I by Trust | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024 |
| 2 | Common | Common Stock | 2024-07-16 | M | A | 12,000 | $24.42 | 12,000 | I by Trust | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-07-16 | M | D | 12,000 | $0.00 | 0 | I by Trust | $24.42 · 2017-07-01 to 2026-06-30 | 12,000 Common Stock |